118 related articles for article (PubMed ID: 9830671)
1. Evaluation of side effects after nicotine nasal spray in patients with chronic rhinitis.
Bende M; Burian P; Danielsson GP; Kruse E; Millqvist E; Säwe U
Rhinology; 1998 Sep; 36(3):98-100. PubMed ID: 9830671
[TBL] [Abstract][Full Text] [Related]
2. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
Hurt RD; Dale LC; Croghan GA; Croghan IT; Gomez-Dahl LC; Offord KP
Mayo Clin Proc; 1998 Feb; 73(2):118-25. PubMed ID: 9472993
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study.
Hjalmarson A; Franzon M; Westin A; Wiklund O
Arch Intern Med; 1994 Nov; 154(22):2567-72. PubMed ID: 7979853
[TBL] [Abstract][Full Text] [Related]
4. Utilization of nicotine nasal spray in smoking cessation.
Montalto NJ; Garrett SD
J Am Osteopath Assoc; 1998 Mar; 98(3):160-4. PubMed ID: 9558832
[TBL] [Abstract][Full Text] [Related]
5. Are nicotine replacement strategies to facilitate smoking cessation safe?
Lavelle C; Birek C; Scott DA
J Can Dent Assoc; 2003 Oct; 69(9):592-7. PubMed ID: 14653935
[TBL] [Abstract][Full Text] [Related]
6. A nicotine mouth spray for smoking cessation: a pilot study of preference, safety and efficacy.
Bolliger CT; van Biljon X; Axelsson A
Respiration; 2007; 74(2):196-201. PubMed ID: 17108670
[TBL] [Abstract][Full Text] [Related]
7. Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
Schneider MP; van Melle G; Uldry C; Huynh-Ba M; Fallab Stubi CL; Iorillo D; Burnier M; Zellweger JP
Nicotine Tob Res; 2003 Oct; 5(5):719-27. PubMed ID: 14577988
[TBL] [Abstract][Full Text] [Related]
8. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
[TBL] [Abstract][Full Text] [Related]
9. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.
Gourlay SG; Benowitz NL
Clin Pharmacol Ther; 1997 Oct; 62(4):453-63. PubMed ID: 9357397
[TBL] [Abstract][Full Text] [Related]
10. Clinical observations with Paxirasol nasal spray.
Szabadka H
Ther Hung; 1992; 40(1):31-6. PubMed ID: 1585283
[TBL] [Abstract][Full Text] [Related]
11. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
Ray R; Jepson C; Wileyto EP; Dahl JP; Patterson F; Rukstalis M; Pinto A; Berrettini W; Lerman C
Nicotine Tob Res; 2007 Nov; 9(11):1237-41. PubMed ID: 17978999
[TBL] [Abstract][Full Text] [Related]
13. Asthma exacerbation after administration of nicotine nasal spray for smoking cessation.
Roth MT; Westman EC
Pharmacotherapy; 2002 Jun; 22(6):779-82. PubMed ID: 12066970
[TBL] [Abstract][Full Text] [Related]
14. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
[TBL] [Abstract][Full Text] [Related]
15. Case studies of three pregnant smokers and their use of nicotine replacement therapy.
Hotham ED; Gilbert AL; Atkinson ER
Midwifery; 2005 Sep; 21(3):224-32. PubMed ID: 15967546
[TBL] [Abstract][Full Text] [Related]
16. The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program.
Alberg AJ; Stashefsky Margalit R; Burke A; Rasch KA; Stewart N; Kline JA; Ernst PA; Avey A; Hoffman SC
Addict Behav; 2004 Dec; 29(9):1763-78. PubMed ID: 15530720
[TBL] [Abstract][Full Text] [Related]
17. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
Tarchalska B; Gotlib T; Samoliński B
Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
[TBL] [Abstract][Full Text] [Related]
18. Developments in pharmacotherapy for tobacco dependence: past, present and future.
Foulds J; Steinberg MB; Williams JM; Ziedonis DM
Drug Alcohol Rev; 2006 Jan; 25(1):59-71. PubMed ID: 16492578
[TBL] [Abstract][Full Text] [Related]
19. Treatment resistant smokers: a pilot study of nicotine nasal spray and inhaler.
Hughes JR; Grass JA; Pillitteri JL
J Addict Dis; 2000; 19(1):95-100. PubMed ID: 10772606
[TBL] [Abstract][Full Text] [Related]
20. Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial.
Munafò MR; Johnstone EC; Wileyto EP; Shields PG; Elliot KM; Lerman C
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):398-400. PubMed ID: 16492936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
